Skip to content

Nebulized colistin in pneumonia

Comparison of efficacy of Colistin IV, Colistin Nebulized with Colistin IV, Meropenem in the treatment of ventilator associated pneumonia caused by MDR gram negative microorganisms, a randomized clinical trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190616043906N1
Enrollment
42
Registered
2020-03-01
Start date
2020-01-12
Completion date
Unknown
Last updated
2020-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ventilator-associated pneumonia. Pneumonia due to Klebsiella pneumoniae

Interventions

Intervention 1: Colistin 9MIU loading dose as iv infusion over 1 hour then 4.5MIU every 12 hour as iv infusion over 1 hour + Colistin nebulized 2 MIU every 8 hour using jet nebulizer for at least 7 da

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to No maximum

Inclusion criteria

Inclusion criteria: Diagnosis of pneumonia 48 hours after intubation (radiographical, laboratory and clinical findings along with a positive tracheal aspirate culture)

Exclusion criteria

Exclusion criteria: Signs of previous pneumonia at the time of intubation No concomitant antibiotics indicated to treat pneumonia other than the study (but allowed for other infections) Patients with a positive culture but no clinical and radiological findings for pneumonia An antibiogram sensitive to any antibiotocs else than polymixins Any history of allergy and seizure caused by Carbapenems/Colistin

Design outcomes

Primary

MeasureTime frame
Clinical response of pneumonia to the treatment regimen. Timepoint: Days 2 and 7. Method of measurement: Evaluating vital signs, oxygenation, laboratory and hemodynamic parameters.;Incidence of acute kidney injury. Timepoint: Days 2 and 7. Method of measurement: According changes in serum creatinine levels and urine volume.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Khalili

Tehran University of Medical Sciences

khalilih@tums.ac.ir+98 21 6658 1598

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026